novel treg-modulating immunotherapy targets inflammation in als
Published 10 days ago • No plays • Length 50:11Download video MP4
Download video MP3
Similar videos
-
3:10
tresr trial: novel atr inhibitor, rp-3500, for advanced solid tumors
-
30:45
novel non-immunotherapy targets and agents in gastroesophageal cancer
-
5:50
coya therapeutics (nasdaq: coya) promising als treatment
-
1:06:59
dr. michael mcgrath on modulating systemic immunity as treatment for als
-
30:45
novel non immunotherapy targets and agents in gastroesophageal cancer
-
8:07
als cure is possible - 5 rules i learned to be true
-
48:50
microglia regulation of selective neuronal vulnerability associated with als by dr. ajami
-
1:49:27
a comprehensive functional medicine approach to als with dr. shelena lalji
-
1:10
short #7: coya's treg cell therapy vs. car treg approaches
-
0:57
cns inflammation in ms: a novel target in progressive disease
-
1:49
novel potential huntington’s treatments
-
22:33
novel therapies beyond immunotherapy for gi malignancies
-
47:01
advancing the management of mds and aml: novel immune-based approaches
-
25:34
novel immunotherapies and combinations
-
53:31
fundamentals of t cell-based immunotherapy - nicholas restifo
-
58:34
gut-brain and neural inflammation in als
-
1:12
novel immune checkpoint inhibitor combinations for tnbc treatment
-
47:09
novel immunotherapy on horizon. targeting immune checkpoints in cancer
-
1:11
acf | immunotherapy explained
-
3:24
novel immunotherapy agents on the horizon for lung cancer
-
35:29
mark exley: phosphopeptide neoantigens for tumor immunity: novel therapeutic options
-
1:11
the development of new gene therapies to address unmet needs in als